3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
16
Unknown
8
Terminated
4
Withdrawn
1
Suspended
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
6
Stomach Neoplasms
5
Melanoma
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Leukemia, Myeloid, Acute
4
Glioblastoma
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Neoplasms
3
Glioma
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peritoneal Neoplasms
2
Osteosarcoma
2
Nasopharyngeal Carcinoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Mesothelioma, Malignant
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Diffuse Intrinsic Pontine Glioma
2
Warts
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Interventions
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Suspended
×
Drug-Related Side Effects and Adverse Reactions
×
Clear all
NCT04824352
2024-05-14
AIEO
Peking University People's Hospital
Phase 2
Suspended
44 enrolled